Overall rank by patents
#855
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Medtronic Vascular, Inc.
USPTO PatentsView assignee record — 533 granted patents across 55 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
533
Total patents granted
55
CPC technology areas
16.6
Avg claims per patent
+35%
5-year filing velocity
Portfolio overview
Medtronic Vascular, Inc. has been granted 533 US utility patents between 2015 and 2025, placing Medtronic Vascular, Inc. at rank #855 across all assignees tracked by PlainPatent. This portfolio spans 55 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.6 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Medtronic Vascular, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 63.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 306 grants, compared with 227 in the 2015–2019 window — a +35% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Medtronic Vascular, Inc.'s 16.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 55 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medtronic Vascular, Inc. against peers pursuing similar technology classes.
How does Medtronic compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Medtronic Vascular ◀ 533
Medtronic Vascular, Inc.
533 patents
What this shows Medtronic holds 533 patents — placing it at rank #855 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 42 | 7.9% |
| 2016 | 47 | 8.8% |
| 2017 | 34 | 6.4% |
| 2018 | 41 | 7.7% |
| 2019 | 63 | 11.8% |
| 2020 | 65 | 12.2% |
| 2021 | 46 | 8.6% |
| 2022 | 56 | 10.5% |
| 2023 | 61 | 11.4% |
| 2024 | 49 | 9.2% |
| 2025 | 29 | 5.4% |
Which technologies does Medtronic Vascular, Inc. patent most?
Top 15 of 55 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing
Frequently Asked Questions
How many patents does Medtronic Vascular, Inc. hold?
Medtronic Vascular, Inc. holds 533 US granted patents filed between 2015 and 2025, spanning 55 technology areas.
What is Medtronic Vascular, Inc.'s Innovation Score?
Medtronic Vascular, Inc. has an Innovation Score of 63.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Medtronic Vascular, Inc. focus on?
Medtronic Vascular, Inc.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 383 patents. The company has filed patents in 55 CPC subclasses total.
Is Medtronic Vascular, Inc.'s patent filing rate increasing or decreasing?
Medtronic Vascular, Inc.'s recent filing velocity is +35% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Medtronic Vascular, Inc.'s patents?
Medtronic Vascular, Inc.'s patents average 16.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Medtronic Vascular, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
A61F technology
Medtronic Vascular, Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders
See where Medtronic Vascular, Inc. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
